Rucaparib Withdrawn Phase 2 Trials for Retinopathy, Diabetic / Diabetes Mellitus (DM) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00457470A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)